E-health Market To Receive Overwhelming Hike In Revenues By 2027

According to the report by Allied Market Research, the global E-Health market is estimated to register a CAGR of 14.5% from 2020 to 2027. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists in determining growing segments and determining further steps to capitalize on lucrative segments. Regional landscape is helpful in determining opportunities and driving factors of each region and taking further steps.

E-health is the delivery of healthcare using modern electronic information and communication technologies when healthcare providers and patients are not directly in contact and their interaction is mediated by electronic means. Among other things, the services that are thus provided include physical and psychological diagnosis and treatment, telepathology, vital signs monitoring, electronic prescribing, teleconsultation, and others. Furthermore, automated and interoperable healthcare information systems improve medical care, minimize healthcare costs, reduce manual errors, and enhance patient satisfaction, while optimizing reimbursement for ambulatory and inpatient healthcare providers.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/10531

The COVID-19 pandemic is expected to present growth opportunities for e-health market in the future. The e-health market includes major suppliers such as Cerner Corporation, GE Healthcare, and Allscripts.

These suppliers have their manufacturing facilities across North America, Asia-Pacific, Europe, South America, and RoW. For instance, In April 2020, GE Healthcare extended its longtime collaboration with Microsoft to launch a cloud-based COVID-19 patient monitoring software for health systems, which will further boost the market growth. In addition, e-health providers has undertaken the task of providing a global overview of the e-health solutions available for COVID-19. Solution providers, consultants advising the healthcare system, and healthcare professionals have been prompted on the internet to contribute with solutions for COVID-19. Many e-health provider companies providing solutions across institutions, geographies, and countries.

The growth of the global e-health market is majorly driven by extensive use of software & ICT healthcare, surge in need to manage regulatory compliance through use of e-health solution, availability of infrastructure for implementation of e-health and safe and adequate storage of data. Furthermore, with fast and easy data sharing, e-health solutions foster collaboration among healthcare providers, while enabling to improve patient outcomes and increasing patient safety. However, reluctance among medical professionals to adopt advanced e-health solutions and high cost of deployment and maintenance of e-health solutions hinder the market growth. Conversely, growth opportunities in emerging nations; expansion of mHealth, telehealth, and remote patient monitoring markets; and rise in use of e-health solutions in outpatient care facilities are expected to provide lucrative growth opportunities for the market growth.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/10531

By product, the medical apps segment is anticipated to grow with the largest share throughout the forecast period. This is attributed to increase significantly, owing to rise in demand for quality healthcare services & solutions, increase in acceptance of mHealth practices, surge in demand for improved patient safety & patient care, and increase in government initiatives to promote healthcare information technology (HCIT). Moreover, surge in adoption of smartphones, tablets, and other devices notably contributes toward the growth of the market.

North America accounted for the highest revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027, due to favorable regulatory scenario regarding to e-health, high adoption of e-health solutions to curtail soaring healthcare costs, regulatory requirements regarding patient safety, and presence of a large number of e-health companies, such as Allscripts Healthcare Solutions, Cerner Corporation, GE Healthcare, and McKesson Corporation, Infor, Inc.

The Major Key Players Are:

Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., Cisco Systems, Inc., InTouch Health, International Business Machines Corporation (IBM), General Electric Company (GE Healthcare), Medtronic plc., UnitedHealth Group (Optum), Koninklijke Philips N.V., and Siemens Healthineers.

Key Findings Of The Study

• By product, the medical apps segment occupied 41.7% share of the global e-health market in 2019.
• On the basis of end user, the healthcare consumers segment is anticipated to grow with the highest CAGR throughout the forecast period.
• Region wise, the Asia-Pacific e-health market is anticipated to exhibit a CAGR of 23.02% during the forecast period.

Access Full Report @ https://www.alliedmarketresearch.com/ehealth-market-A10166

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Blood Pressure Monitoring Devices Market Statistics 2020: Top Impacting Factors That Can Win the Industry Worldwide

 

Blood pressure is considered as one of the main risk factors for chronic heart disease. Advanced blood pressure monitoring devices are used for regular remote monitoring and transmission of the blood pressure data to the physicians. Factors such as increase in geriatric population, rise in inclination towards home monitoring, and upsurge in incidence rate of chronic diseases, such as cardiovascular disorders and obesity, are expected to drive the market. Moreover, innovations in blood pressure monitoring devices, (such as introduction of digital blood pressure monitors) and rise in awareness among patients regarding advanced devices are expected to fuel the market growth. However, lack of awareness about these devices in low- and middle-income economies hampers the market growth.

The global blood pressure monitoring devices market was valued at $1,981 million in 2015, and is estimated to reach $2,926 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. Digital blood pressure monitoring devices segment held around two-fifths share of the total market in 2015.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2166

Digital blood pressure monitoring devices segment is anticipated to dominate the global blood pressure monitoring devices market owing to the increase in the global incidence of hypertension. However, ambulatory blood pressure monitors segment is projected to be the fastest growing segment, as a result of increase in the outpatient cases and reimbursement support from the government.

Digital BP monitors at hospitals & clinics segment is expected to dominate the global blood pressure monitoring devices market, as these devices facilitate easy and early detection of a patients deteriorating health condition, thereby, enabling speedy intervention and diagnosis of diseases. However, the ambulatory BP monitoring devices at ambulatory surgical centers (ASCs) market is projected to be the fastest growing segment, owing to increase in the number of outpatient cases.

Inquire before buying @  https://www.alliedmarketresearch.com/purchase-enquiry/2166

North America was the highest revenue contributor to the global revenue in 2015, accounting for about two-fifths share, and is expected to maintain this trend. This is attributed to the increase in prevalence of hypertension, growth in awareness among patients about cost-effective blood pressure monitoring devices, and availability of advanced healthcare facilities in North American countries. However, Asia-Pacific is expected to grow at the highest rate, owing to its high population base, incomes, and improvement in patient awareness about advanced blood pressure monitoring devices.

The Major Key Players Are:

·        A&D Company, Limited

·        Contec Medical Systems Co., Ltd.

·        General Electric Company

·        Halma plc

·        Hill-Rom Holdings, Inc.

·        Koninklijke Philips N.V.

·        Masimo Corporation

·        Nihon Kohden Corporation

·        Omron Corporation

·        Smiths Group Plc.

Key Findings of the Blood Pressure Monitoring Devices Market Study:

·        Based on product type, in 2015, digital blood pressure monitoring devices segment accounted for around two-fifths share of the total market.

·        Home environment segment is expected to grow at a significant CAGR of 6.5%, as these devices can be easily used by a patient and do not require trained professionals for operating the device.

·        LAMEA is projected to be the one of the fastest growing region, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of hypertension, and increased disposable income of the population.

·        In 2015, Japan and China jointly accounted for about two-thirds share of the Asia-Pacific blood pressure monitoring devices market.

Access Full Report @  https://www.alliedmarketresearch.com/blood-pressure-monitoring-devices-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Ophthalmic Lasers market CAGR Attempts To Break Record Estimating By 2027

A laser is a device that emits light through a process of optical amplification based on the stimulated emission of electromagnetic radiation. This device is used increasingly in the area of ophthalmology as there is an understanding of laser-tissue interactions in this medical application, such as ophthalmology. This results into use of medical lasers in treating a wide spectrum of eye-related diseases, such as cataract, glaucoma, age-related macular edema, and diabetic retinopathy.

The global ophthalmic lasers market was valued at $1,111 million in 2016, and is projected to reach $1,516 million by 2023, registering a CAGR of 4.5% from 2017 to 2023. The photocoagulation lasers segment dominated the global market, accounting for a share of nearly three-fourths of the total market in 2016.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2013

The factors that drive the ophthalmic lasers market are surge in number of eye-related diseases, advancements in the laser technology, and increased awareness for laser application in the area of ophthalmology. However, stringent safety regulations and high rate of failure of surgeries involving use of lasers limit the market growth. Emerging nations, such as LAMEA and Asia-Pacific, and increasing disposable income are expected to provide major opportunities to the manufacturers of ophthalmic lasers.

The Nd:YAG lasers segment is expected to register highest CAGR of 5.2% from 2017 to 2018. This is attributed to diverse applications of these lasers in the treatment of various eye diseases.

In 2016, North America accounted for a share of two-fifths of the global market, owing to the increase in prevalence of eye-related diseases and high adoption of technologically advanced products. Europe holds the second position in the global ophthalmic lasers market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2013

The major companies profiled Are:

Carl Ziess Meditec Ag, Novartis AG, Topcon Corporation, Ellex Medical Corporation, Quantel Inc., Iridex Corporation, Nidek Co., LTD., Lumenis, Abbott Laboratories, and Ziemer Ophthalmic Systems.

Key Findings of the Ophthalmic Lasers Market:

• The photodisruption lasers segment is projected to grow at CAGR of 3.0% during the forecast period.
• North America accounted for a dominant position in the regional landscape in 2016, accounting for two-fifths share of the total market.
• In 2016, the eye clinics segment accounted for a share of more than one-fourth of the total ophthalmic lasers market.
• The glaucoma surgery segment accounted for the highest CAGR of 6.6% in the global ophthalmic lasers market, by application in 2016.

Access Full Report @ https://www.alliedmarketresearch.com/ophthalmic-laser-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Medical personal protective industry – Know Latest Trends & Forecast for Long-Term Business Planning

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the medical personal protective industry, a vital part of the healthcare sector, also witnessed new growth opportunities.

At present, the medical personal protective industry is witnessing a tremendous growth as medical personal protective products are playing a crucial role to combat the pandemic and monitor the patients. The medical personal protective products such as gowns, gloves, sets, coveralls, masks, caps, shoe covers, and others are facing a huge demand, owing to their immense usage in hospitals, clinics, and other healthcare service centers. The medical personal protective industry manufacturers are expanding their production capacity to manufacture products in response to the COVID-19 pandemic. Rise in the number of COVID-19 cases worldwide and the surge in need for healthcare workers are the factors expected to drive the demand for medical personal protective products. In addition, due to the quick spread of the virus, healthcare professionals associated with collection of specimens require proper protection including coveralls, masks, caps, and others to prevent themselves from getting infected. Moreover, medical nonwoven products form a crucial part of the personal protective equipment (PPE) worn by healthcare professionals. Therefore, growth in prevalence of contagious diseases and COVID-19 is anticipated to fuel the growth of the medical personal protective industry.

However, the outbreak led to a sudden change in scenario, sending mixed waves to the business flow. Some parts of the industry were hit in a negative manner whereas others experienced growth, owing to unexpected rise in demand for products and shortage of medical personal protective products in some countries.

Impact of COVID-19 on several industries in context with the medical personal protective industry

The medical personal protective products are used to protect the wearer and/or the patient from the spread of illness or infection during medical procedures and examinations. The medical personal protective products typically include gowns, gloves, sets, coveralls, masks, goggles, head caps, and shoe covers. Gloves are a type of personal protective equipment (PPE) designed to protect staff from microbial contamination, or from contact with certain chemicals, and cross-transmission from healthcare associated infections. Gowns are safe, comfortable, and flexible, and are used by physicians and other medical personnel to protect them from infectious fluids, bacteria, and viruses. Coverall is a one of the solutions of protective apparel that covers all the wearer to prevent the cross-contamination during work activities. These medical protective clothing are aimed to cover the entire body, including head, lower legs, back, and in some cases, feet. Masks are used to ensure an efficient filtration of the breath and are widely used in prevention of airborne diseases during an epidemic or pandemic. The caps are chiefly used by the surgical staff to prevent the hair strands or dandruff particles from contaminating a sterile area. Shoe covers are used by patients and physicians to prevent the transmission of infections into the operation theatre through the footwear.

The COVID-19 outbreak impacted the medical personal protective segment in a positive manner. The COVID-19 virus is mostly transmitted through the respiratory routes and supposedly by transfusions. Social-distancing is observed as an effective measure to stop the spread of COVID-19 disease and has triggered the demand for gloves, surgical masks, and N95 respirators, since masks are considered to be the first line of defense against the viral infection. Moreover, WHO, in March 2020, advised and recommended wearing a mask in public spaces as a measure to curb the spread of coronavirus. Recently, government of India (GOI) made the masks mandatory for employees and laborers working across all industry verticals such as manufacturing, aerospace, and healthcare sectors, to combat the COVID-19 outbreak. In addition, in May 2020, Centers for Disease Control and Prevention (CDC) recommended that the use of the gloves should be during food handling, cleaning, gardening, trades, or caring for someone who is sick, and while in contact with blood, stool, or body fluids, such as saliva, mucus, vomit, and urine. If gloves are not used appropriately, they can pose a risk of spreading germs, putting workers and others at risks.

The manufacture of medical gloves for health workers is one industry that has experienced significant growth, with over 300 billion rubber gloves now being used each year. The Malaysian firm Meditech Gloves is expected to begin production of natural gloves that can biodegrade 100 times faster than synthetic, petroleum-based options. Key players of gloves such as Supermax Corporation Berhad and Top Glove Corporation Bhd., and others are focusing toward increase in production of gloves to sustain the pandemic. While the COVID-19 pandemic rages across the world, the demand for medical gloves has increased globally.

However, trade and transport restrictions, quarantine measures, cross-border movement controls, and disruptions in production have reduced the supply of medical personal protective products across the world. One of the major mask manufacturers and suppliers is China, which was under lockdown for months. This has adversely affected the surgical product supply chain activities across the globe. Subsequently, several domestic manufacturers have stepped in for manufacturing medical personal protective products in several countries. The companies are facing substantial challenges to ramp up the production capacities to help mitigate the medical personal protective products supply shortage. These challenges are expected to pose a threat to the growth of the medical personal protective industry in the coming years. However, the market players are strategically planning to strengthen the production capacities of products by collaborating with other companies to overcome the shortage.

TABLE 01.      GLOBAL GLOVES MARKET, 2017–2025 ($Million)

	2017	2018	2019	2020	2021	2022	2023	2024	2025
Global Market	11,460.63	12,471.83	13,422.02	17,882.10	23,693.78	27,603.26	30,170.36	32,553.82	35,027.91

Source: Primary & Secondary Research and AMR Analysis

TABLE 02.       Europe nonwoven products market, 2017–2025 ($THOUSAND)

	2017	2018	2019	2020	2021	2022	2023	2024	2025
Global Market	1,528,922.4	1,631,912.6	1,723,636.5	5,868,821.7	2,617,494.5	2,485,578.5	2,615,077.1	2,793,686.9	3,014,667.5

Source: Primary & Secondary Research and AMR Analysis

Expectations from the medical personal protective industry

The coronavirus (COVID-19) pandemic is a constantly-evolving condition that is affecting all communities across the globe. The medical personal protective industry should monitor all developments and adhere to recommendations from the Center of Disease Control (CDC) and World Health Organization (WHO), and local & state health agencies. The medical personal protective manufacturer should implement all recommended safety precautions and take additional steps to avoid spread of COVID-19 within their production area. The manufacturer should follow recommended guidelines for risk reduction such as social distancing, frequent disinfection to high touch items, availability of hand sanitizers in all common areas, and provision of training and updates to all employees on safety precautions. Moreover, the quality of the product should not be affected, as demand for medical personal protective is more.  

Major medical personal protective key players are 3M Company, Asahi Kasei Corporation, B. Braun Melsungen AG, Cardinal Health, Freudenberg & Co. KG, Hartmann Group, Investor AB (Mölnlycke Health Care AB), Kimberly-Clark Corporation, Hartalega Holdings Berhad, Honeywell International Inc., Medline Industries, Inc., and Zarys International Group. The expectation from the medical personal protective industry is to support governments to fight against the COVID-19. For instance, in November 2020, four major glove companies namely Top Glove Corp Bhd., Hartalega Holdings Bhd., Supermax Corporation Bhd., and Kossan Rubber Industries Bhd., contributed $98.70 million to help the government in its fight against COVID-19. Furthermore, in March 2020, Supermax Corporation Berhad has donates 1 million nitrile powder-free medical gloves to COVID-19 frontlines. They are to be distributed to Malaysian government hospitals, police stations, and the healthcare industry’s first responders, to combat the COVID-19 outbreak in Malaysia.

Post COVID-19 Scenario

As nations are emerging out of strict lockdowns, economy is expected to take time to stabilize gradually. Players operating in the medical personal protective industry are anticipated to face new challenges related to different aspects. For instance, products shortage would lead to a negative impact on supply to various countries. However, the scenario is expected to change upon increasing the production of medical personal protective products. Similarly, decision making management of medical personal protective companies is anticipated to face challenges such as improvement of liquidity, management of working capital, better management of expenditures, and redefined contracts with suppliers. Pending surgical procedures are expected to be completed post COVID-19 pandemic. Such number of pending or suspended surgeries is expected to result into an exponential growth of the medical personal protective industry along with recovery from COVID pandemic.

Recent news in the medical personal protective industry during the pandemic

The medical personal protective key players around the globe are entering into collaboration and partnership.

In September 2020, SHOWA, a U.S. manufacturer of single-use PPE gloves, and Choctaw Kaul Distribution Company announced a strategic partnership to meet the rise in U.S. demand for Personal Protective Equipment (PPE) gloves that are critical to protecting the U.S. frontline workers and citizens during the COVID-19 pandemic.

In August 2020, Ansell Healthcare Products LLC, a global leader in hand protection solutions has signed a distribution partnership with OneMed; a provider of medical supplies and support systems which has an existing distribution network in the Nordics.

In May 2020, Dow collaborated with nine key partners across myriad of industries to develop & donate 100,000 isolation gowns to support frontline workers in Texas, Louisiana and Mexico.

In April 2020, Nature Works and the Nonwovens Institute (NWI) announced a strategic partnership to produce at least 10 million N95 surgical masks.

Medical Device Outsourcing Market: Comprehensive study explores Huge Growth in near Future

Medical device outsourcing involves taking the assistance of third-party companies to manufacture medical devices. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as spine disorders, diabetes, and cardiovascular diseases, are expected to drive the market growth. Moreover, outsourcing also allows the companies to focus on their core activities, which in turn boosts the market growth. However, threat of loss of confidential information is expected to impede the market growth.

The global medical device outsourcing market was valued at $44,326 million in 2016, and is projected to reach $83,952 million by 2023, growing at a CAGR of 9.5% from 2017 to 2023. The electronics segment held more than two-fifth share of the total market in 2016.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1436

Finished device manufacturing segment is expected to dominate the market throughout the analysis period, owing to increase in demand for affordable devices. Testing and regulatory support services is expected to register highest CAGR of 10.0% during the forecast period.

Asia-Pacific is projected to register the highest CAGR of 10.5% during the forecast period, owing to low labor costs, low overhead expenses, and improving technical abilities to produce class III medical devices. In addition, tax breaks and incentives such as lowered tariffs and duties to foreign companies in these nations offer a lucrative opportunity for the market growth.

The Major Key Players Are:

• Celestica, Inc.
• Creganna
• Flextronics International Ltd.
• Heraeus Holding
• Integer Holdings Corporation
• Nortech Systems, Inc.
• Plexus Corp.
• Sanmina Corporation
• Tecomet, Inc.
• West Pharmaceutical Services, Inc.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1436

Key Findings of the Medical Device Outsourcing Market:

• Finished goods segment is projected to grow at a CAGR of 10.0% during the forecast period.
• Class II devices accounted for more than half of the share of the global medical device outsourcing market, in 2016.
• In terms of application, cardiovascular segment is expected to register the highest CAGR of 9.9% during the analysis period.
• Prototype & development is expected to grow at the CAGR of 10.0% during the forecast period.
• France and Germany collectively contributed for more than two-fifth share of the European medical device outsourcing market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific medical device outsourcing market in 2016.

Access Full Report @ https://www.alliedmarketresearch.com/medical-devices-outsourcing-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Nuclear Medicine Market Top Scenario, SWOT Analysis, Business Overview & Forecast 2027

 

The global radiopharmaceuticals market is expected to garner $8,207.5 million by 2022.

The global radiopharmaceuticals market is poised to grow at a significant pace, owing to growing demand for non-invasive techniques, availability of effective cancer treatment, and ability to observe the functioning of the organ from outside the body. Furthermore, increasing incidence of cancer & cardiovascular aliments, growing demand for alpha radio immunotherapy-based targeted cancer treatment, mounting call for nuclear imaging techniques, and advancements in radiotracers are expected to open new avenues in the radiopharmaceuticals market. Factors that are expected to drive the use of radiopharmaceuticals include changing lifestyle, elevated levels of stress, and ability to identify various diseases sooner than other diagnostic tests. However, factors such as supply volatility & logistical challenges, stringent regulatory vigil, and competition from conventional diagnostic procedures are anticipated to impede the market growth.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1131

The oncology segment contributed more than half of the market share in the overall radiopharmaceuticals market in 2015 and is expected to continue the same trend owing to perpetual rise in the number of cancer cases. The SPECT modality segment dominated the radiopharmaceuticals market in 2015, whereas the PET modality segment is anticipated to grow at a comparatively higher CAGR of 8.3% from 2016 to 2022. PET segment is driven by better quality of image and higher precision in diagnosis. Other reasons attributed to its sustained dominance are growing R&D activities especially in developing economies and widening scope of radiopharmaceutical applications such as thyroid, oncology, and bone pain palliation.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1131

The Asia-Pacific radiopharmaceuticals market is expected to offer lucrative growth opportunities during the forecast period owing to aging population and increasing cancer incidences. The leading Asia-Pacific countries, such as China, Japan, and Australia would exhibit a steady growth rate.

The Major Key Players Are:

·        Mallinckrodt plc.

·        General Electric

·        Medtronic Inc.

·        Bayer AG

·        Cardinal Health Inc.

·        Lantheus Medical Imaging, Inc.

·        IBA Group

·        Bracco Imaging S.p.A.

·        NTP Radioisotopes SOC Ltd.

Key findings of Radiopharmaceuticals Market:

• Therapeutics segment is projected to be the fastest growing segment in the radiopharmaceuticals market, registering a CAGR of 16.9% from 2016 to 2022.
• SPECT modality segment is expected to dominate the radiopharmaceuticals market in 2015 and expected to retain its position throughout the study period.
• Thyroid application segment is expected to exhibit double-digit CAGR of 11%.
• Oncology application segment is expected to continue to lead the radiopharmaceuticals market, accounting for close to 60% share by 2022.
• Asia-Pacific is projected to be the fastest growing radiopharmaceuticals market, registering a CAGR of 8.4%.

Access Full Report @ https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Life Science Analytics Software Market: Emerging Economies Expected to Influence Growth until 2027

The life sciences industry is moving from treatment to preventive scenarios and management of patient's health outcomes. In addition, early detection of disease patterns and strategic target is the key for effective business strategies. Thus, life science companies are demanding for analytics software that is used to transform data into useful insights. Further, benefits of analytics software in life sciences such as early detection of prescription and treatment patterns, strategizing patient outcomes and achieving better operational quality that drives the intellectual journey of patient centricity further boosts the growth of the global life science analytics software market.

The global life science analytics software market size was valued at $5.35 billion in 2019 and is expected to reach $16.04 billion by 2027 with a CAGR of 12.3% during the forecast period.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6574

The need for improved data standardization and rises in utilization of analytics software, coupled with increase in incidences of chronic diseases boost the life science analytics software market growth. However, data privacy issues and lack of skilled professionals for big data solutions restrict the market growth. Moreover, emergence of social media and its impact on the life science industry offers lucrative opportunities for key market players operating in the analytics software segment.

In additional, such analytics capabilities develop the performance of pharmaceutical manufacturing so that they can deliver safe, effective drugs and other treatment to patients with greater efficiency and assurance. The major applications of analytics software in the life science industry include research & development, clinical trials, sales and marketing support and regulatory compliance. The software helps to beat challenges in data integration and enhance operational efficiency. Furthermore, the integration of artificial intelligence (AI) and machine learning approaches within the life science industry is making drug discovery and development more inventive, time-effective and cost-effective. Thus, enhance the demand for life science analytics software market.

By product, the predictive analytics segment is expected to grow with a highest CAGR from 2020 to 2027, as the software helps to enhance the accuracy of diagnosis & treatment, as well as epidemiology to review possible risk factors for public health.This increase the demand for predictive analytics software to improve patient care and it is expected to be high in the future.

On the basis of application, the sales & marketing segment is expected to grow at the highest CAGR during the forecast period. The is attributed to the rise in adoption of analytics by life science companies to align their sales & marketing campaigns. Surge in importance of post-marketing surveillance also propels the utilization of analytics for sales & marketing in the life science industry.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6574

Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to the surge in prevalence of chronic diseases, growth of the life science industry, rise in adoption of advanced technologies, and growth in focus of major players on increasing their presence in emerging countries

The life science analytics software market is segmented on the basis of product, application, delivery model, end user and region. By product, it is divided into descriptive analytics, prescriptive analytics and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The research & development is further segmented into clinical trials and preclinical trials. On the basis of delivery model, it is bifurcated into on-premise and cloud. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers and third-party administrators (TPAS). Region wise, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.

The Major Key Players Are:

Accenture Plc, ArisGlobal LLC, Chemical Abstracts Services(ACS), Certara, L.P., Clarivate Analytics Plc, Cognizant Technology Solutions Corporation, Dassault Systemes, Deloitte ToucheTohmatsu Limited, IQVIA Holdings Inc., Microsoft Corporation, Oracle Corporation, TIBCO Software Inc.,andVeeva Systems Inc. 

Key Findings Of The Study

• Based on type, the descriptive analytics segment accounted for the largest life science analytics software market share in 2019.
• Based on application, sales & marketing segment is expected to grow at the highest CAGR during the forecast period
• In 2019, North America held the major share of the life science analytics software market.
• By delivery model, cloud based software of life science analytics is expected to grow at the highest CAGR.

Access Full Report @ https://www.alliedmarketresearch.com/life-science-analytics-software-market-A06209

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Airway Clearance System Market Size |Incredible Possibilities and Growth Analysis and Forecast To 2026

Airway clearance is a therapy are used for loosening the mucus in patients suffering from respiratory disorders such as COPD, asthma, cystic fibrosis and others. Major increase in the incidence of respiratory disorders all-inclusive has led to an increased demand of these devices. For instance, according to the Global Initiative for Asthma (GINA), around 300 million people across the world suffer from asthma every year. Further, COPD, was the 3rd leading cause for death, led to the death of 3 million people in 2017. Moreover, for treating these disorders, a variety of airway clearance systems have been introduced in the market, such as positive expiratory pressure (PEP), high frequency chest wall oscillation (HFCWO. However, the positive expiratory pressure (PEP)is the most effective treatment option as compared to the other methods.

The Airway clearance system market size is expected to reach $922 million by 2026, registering a CAGR of 4.7% from 2019 to 2026, in terms of value.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/6426

Significant increase in prevalence of cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD) across the globe is the major factor driving the airway clearance system market growth. For instance, U.S. Cystic Fibrosis Foundation, more than 30,000 people are living with cystic fibrosis in the country. Further, the major factors leading the airway clearance system market growth are increasing concerns of respiratory diseases, such as asthma and emphysema, and rising incidence of respiratory diseases caused due to cigarette consumption. The growth of the airway clearance system market would be boosted due to increase in healthcare expenditure, growth in the use of homecare devices in healthcare industry, and rapid adoption of advanced medical solutions. Currently, most of healthcare practitioners and pulmonary diseases experts prefer a combination of a drug and a device, owing to its fast and effective outcome. However, the factors such as high cost correlated with the airway clearance systems and side effects occurring due to their excessive usage may hamper the airway clearance system market growth

Technological advancements in airway clearances such as providing minimally invasive treatments, surge in awareness among individuals towards self-grooming are the major factors driving the airway clearances market growth. In addition, rise in disposable incomes in developing economies such as China, India, further contributes to the market growth. However, high cost of these devices and a lack of appropriate reimbursement policies are restraining the growth of this market. On the contrary, rise in baby boomer population and the budding trend of body altering across the globe, are anticipated to create lucrative opportunities for the market in near future. In addition, manufacturers are continuously focusing towards improving their products to help users in gaining improved results in a shorter time period with minimal or no incisions.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6426

By type, the positive expiratory pressure (PEP) segment accounted for the majority of airway clearance system market share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to the fact that it is the most used airway clearance systems used for the treatment of cystic fibrosis. However, oscillating PEP device segment is anticipated to grow at the fastest rate during the forecast period

By application, the bronchiectasis segment dominated the airway clearance system market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the surge in surge in incidence of the disease across the globe. For instance, according to British Lung Foundation, around 210,000 people in the UK were living with bronchiectasis in 2016.

The Major Key Players Are:

Allergan plc, Dymedso Inc., Electromed Inc., Ltd., General Physiotherapy Inc Hill-Rom Holdings, Inc., International Biophysical Corporation, Koninklijke Philips N.V. (Philips), Monaghan Medical Corporation, Inc., and PARI GmbH, Thayer Medical.

Key Findings of the Study:

• By type, the positive expiratory pressure (PEP) segment accounted for the highest market share of 27% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
• By region, North America was the major shareholder and accounted for the highest share of 44% in 2018.
• By application, neuromuscular segment is expected to grow at a CAGR of 5.4% during the forecast period.
• By end user, the hospitals segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.

Access Full Report @ https://www.alliedmarketresearch.com/airway-clearance-system-market-A06061

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Opioids Market to witness excellent revenue growth, emerging trends & forecast by 2027

 

Opioid drugs are available legally by prescription, such as oxycodone (OxyContin), hydrocodone (Vicodin), codeine, morphine, and others. However, opioids comprise the illicit drug heroin, synthetic opioids including fentanyl, morphine, and other pain relievers.

The global opioids market is expected to reach $22.3 Billion by 2026, registering a CAGR of 3.2% from 2019 to 2026, in terms of value.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/3556

The opioid market growth is majorly driven by surge in consumption of these drugs to combat pain and rise in geriatric population that are more prone to orthopedic pain. In addition, upsurge in disposable income in developing economies such as India, China, and others contribute to the growth of the market. However, surge in opioid addiction (opioid crisis) across the globe and implementation of stringent government regulation for opioid prescription are the factors anticipated to hamper the market growth. In addition, increase in death rates owing to the overdose of these drugs is a major factor restraining the market growth. For instance, according to the National Institute of Drug Abuse, more than 130 people in the U.S. die daily on overdosing of opioids.

Based on opioid market analysis, the oxycodone segment accounted for 23% of the share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to its increased intake across the globe for pain management. By application, the pain management segment dominated the opioid market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to increase in incidence of migraine, back pain, cancer pain, and others, which in turn fuels the adoption of opioids drugs.

North America accounted for the majority global opioid market share in 2018 and is anticipated to continue this trend during the forecast period. This is attributed to vigorous use and ease of availability of opioid analgesics in this region. However, Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the presence of key players such as Teva Pharmaceuticals, Janssen Pharmaceuticals, Inc., and others in the region. Although opioids are vigorously used for pain management, the market is experiencing slow growth, owing to increase in cases of opioid crisis and deaths due to opioid overdose/misuse.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3556

The Major Key Players Are:

• Purdue Pharma
• Boehringer Ingelheim
• Janssen Pharmaceuticals, Inc.
• Sanofl
• Sun Pharmaceuticals
• Mallinckrodt Pharmaceuticals
• Endo Pharmaceuticals Inc.
• Allergan, Plc
• Pfizer, Inc.

Key Benefits for Opioids Market:

• This report entails a detailed quantitative analysis along with the current opioids market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The market forecast is studied from 2018 to 2026.
• The opioids market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Access Full Report @ https://www.alliedmarketresearch.com/opioids-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.